E.M. (Mick) Kolassa, PhD 
The Evolution and Devolution of Health Insurance
An interesting commercial ran on television recently, in which a homeowner’s insurance customer asks ...
Managed Care: The Force Awakens
I have been saying for years that people in the industry have seriously overstated ...
Loss of Exclusivity? Get What You Can Out of Your Brand
The pharmaceutical industry exists in what is almost a parallel world relative to other ...
Does Your Brand Name Spell Success?
Pharmaceutical marketers work hard to bring basic marketing principles to bear in their markets, ...
Are Drug Prices Really the Problem?
My first day on the job, in pricing for the Upjohn Company in December ...
Why Are Payers Blocking Hep C Drug Access?
Several years ago, I learned a concept that is central to the way I ...
Foolish Followship
Almost 10 years ago I wrote an article called “Fear of Firstness,” which discussed ...
The $1,000 Pill: How Pricing is Decided and its Effects on the Marketplace
In the more than three decades during which I have worked in the pharmaceutical ...
Inside Looking In
Seventeen years ago I wrote that the biggest problems facing the pharmaceutical industry were ...
Being Disruptive In a Blue Ocean of Excellence
I’ve been working in businesses for about 35 years and during that time thousands ...
What If You Really Don’t Have a Value Proposition for Payers?
I have preached the gospel of value-based marketing for years and argue constantly that ...
What the Payer Doesn’t Know
I am frequently contacted by clients who have important questions about their markets, such ...
